TMX Newsfile

IN THE PRESS

Drug Development

Kiora Announces the Acceptance of Late-Breaking Abstract on Phase 1b Study of KIO-301 in Retinitis Pigmentosa at The American Society of Neuroradiology 2023 Meeting

March 30, 2023

·

3 min read

NervGen Pharma Reports 2022 Year End Results and Provides Operational Update Including Plans to Initiate Phase 1b/2a Clinical Trial of Proprietary NVG-291 in Q3 2023

March 30, 2023

·

14 min read

Business

Global Hemp Group Announces Jeff Nagel as Product Manufacturing Advisor

March 30, 2023

·

4 min read

Hemostemix Engages Montreal’s RobboDesign to SEO Its Website to Engage with 236 Million Peripheral Arterial Disease and Critical Limb Ischemia Patients Globally

March 29, 2023

·

8 min read

Policy

Cardiol Therapeutics Announces Year-End 2022 Update on Operations

March 29, 2023

·

15 min read

Novel Therapeutic Solutions are Needed as Autism Rates Increase

March 29, 2023

·

4 min read

Sona Nanotech Grants Options - March 2023

March 29, 2023

·

2 min read

Medinbox partners with Abbott to improve connections and information sharing between physicians in electrophysiology labs worldwide

March 28, 2023

·

5 min read

Defence to Complete a Final Pre-Clinical Study Prior to IND Filings for the AccuTOX(TM) Phase I Cancer Trial at the City of Hope National Medical Center and Beckman Research Institute

March 28, 2023

·

5 min read

Moss Introduces New Gut Microbiome Test

March 28, 2023

·

4 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750